D047630Chemicals & DrugsD04.345.566.297D12.644.641.297110.999927Depsipeptidesprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonWake Forest School of MedicineSamuelLentzSamuel S. Lentz MD36.08959100000000-80.26859900000000907Lentz, SamuelProfessor25762519Cedeno-Laurent F, Singer EM, Wysocka M, Benoit BM, Vittorio CC, Kim EJ, Yosipovitch G, Rook AHClinical immunology (Orlando, Fla.)Cedeno-Laurent F, Singer EM, Wysocka M, Benoit BM, Vittorio CC, Kim EJ, Yosipovitch G, Rook AH. Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities. Clin Immunol. 2015 May; 158(1):1-7.Clin Immunol2015-03-08T00:00:002015Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities.28646165Ohshiro T, Kobayashi K, Ohba M, Matsuda D, Rudel LL, Takahashi T, Doi T, Tomoda HScientific reportsOhshiro T, Kobayashi K, Ohba M, Matsuda D, Rudel LL, Takahashi T, Doi T, Tomoda H. Selective inhibition of sterolO-acyltransferase 1 isozyme by beauveriolide III in intact cells. Sci Rep. 2017 06 23; 7(1):4163.Sci Rep2017-06-23T00:00:002017Selective inhibition of sterolO-acyltransferase 1 isozyme by beauveriolide III in intact cells.Obstetrics and Gynecology, GYN Oncologytrue1ProfessorProfessor16995669Ohshiro T, Namatame I, Nagai K, Sekiguchi T, Doi T, Takahashi T, Akasaka K, Rudel LL, Tomoda H, Omura SThe Journal of organic chemistryOhshiro T, Namatame I, Nagai K, Sekiguchi T, Doi T, Takahashi T, Akasaka K, Rudel LL, Tomoda H, Omura S. Absolute stereochemistry of fungal beauveriolide III and ACAT inhibitory activity of four stereoisomers. J Org Chem. 2006 Sep 29; 71(20):7643-9.J Org Chem2006-09-29T00:00:002006Absolute stereochemistry of fungal beauveriolide III and ACAT inhibitory activity of four stereoisomers.17390588Ohshiro T, Rudel LL, Omura S, Tomoda HThe Journal of antibioticsOhshiro T, Rudel LL, Omura S, Tomoda H. Selectivity of microbial acyl-CoA: cholesterol acyltransferase inhibitors toward isozymes. J Antibiot (Tokyo). 2007 Jan; 60(1):43-51.J Antibiot (Tokyo)2007-01-01T00:00:002007Selectivity of microbial acyl-CoA: cholesterol acyltransferase inhibitors toward isozymes.19336931Ohshiro T, Matsuda D, Nagai K, Doi T, Sunazuka T, Takahashi T, Rudel LL, Omura S, Tomoda HChemical & pharmaceutical bulletinOhshiro T, Matsuda D, Nagai K, Doi T, Sunazuka T, Takahashi T, Rudel LL, Omura S, Tomoda H. The selectivity of beauveriolide derivatives in inhibition toward the two isozymes of acyl-CoA: cholesterol acyltransferase. Chem Pharm Bull (Tokyo). 2009 Apr; 57(4):377-81.Chem Pharm Bull (Tokyo)2009-04-01T00:00:002009The selectivity of beauveriolide derivatives in inhibition toward the two isozymes of acyl-CoA: cholesterol acyltransferase.0.01466430.01466431research area of0.6291240.05866146subject area for